Nikkei BP Enters Partnership with Cambridge Healthtech Associates to Distribute CHA Advances Reports in Japan

Tokyo, Japan and Waltham, Mass. – December 1, 2005 — Nikkei Business Publications, Inc. (Nikkei BP) is pleased to announce an exclusive agreement with Cambridge Healthtech Associates (CHA), the leading provider of research reports and collaborative solutions for the biopharmaceutical industry, wherein Nikkei BP will distribute CHA's Advances Reports to the Japanese healthcare market through its numerous print and online channels.

Japan is the second largest pharmaceutical market in the world. As a major operating unit of the Nikkei  media group — the dominant provider of business and financial information in Japan — Nikkei BP brings unparalleled access to decision makers throughout the Japanese medical world, including pharmaceutical and biotechnology companies, vendors of products and services, physicians, and healthcare provider organizations.

"CHA Advances Reports are recognized as the leading source of insight into developments affecting the global pharmaceutical and biotechnology industries," said Mitsuru Miyata, Managing Editor of Bio Center, Nikkei BP. "We are very pleased to bring these high-quality reports to the Japanese market, and believe that our readers will benefit from keeping current with the latest biomedical technologies and their business implications."

"We are honored that Nikkei Business Publications has chosen Cambridge Healthtech Associates as a partner in providing insightful content to the Japanese biopharmaceutical R&D market through our Advances Reports," said Gene Williams, CEO of Cambridge Healthtech Associates. "Nikkei Business Publications has established the leading position in the Japanese market for biopharmaceutical information based on their outstanding reputation for quality, and we look forward to a productive partnership."

About CHA

Cambridge Healthtech Associates is the leading provider of information services and collaborative process improvement to the biopharmaceutical industry.  It focuses on areas of opportunity to improve the economics of new product development. Its product line includes Advances Reports, Dynamic Intelligence Services, and Pathways. Its clients include virtually all global biopharmaceutical companies, including the world's largest pharmaceutical companies. www.chacorporate.com

For more information about CHA, please contact Michael Goodman by phone at 781-547-0205 or by e-mail at mgoodman@chacorporate.com.

For further details, please contact:
Yasuji Yamada
phone: +813-5210-8243
http://www.nikkeibp.com
e-mail: yamada@nikkeibp.co.jp